Browse > Article
http://dx.doi.org/10.4046/trd.2015.78.3.253

First Outcome of MDR-TB among Co-Infected HIV/TB Patients from South-West Iran  

Motamedifar, Mohammad (Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences)
Ebrahim-Saraie, Hadi Sedigh (Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences)
Abadi, Ali Reza Hassan (Shiraz HIV/AIDS Research Center, Shiraz University of Medical Science)
Moghadam, Mahboube Nakhzari (Department of Bacteriology & Virology, School of Medicine, Shiraz University of Medical Sciences)
Publication Information
Tuberculosis and Respiratory Diseases / v.78, no.3, 2015 , pp. 253-257 More about this Journal
Abstract
Background: Tuberculosis (TB) is the leading cause of mortality among human immunodeficiency virus (HIV) patients and the majority of them occur in developing countries. The aims of the present study were to determine the frequency of HIV/TB co-infection and other probable associated factors. Methods: This 10 year retrospective study was conducted on 824 HIV patients in the south-west of Iran. HIV infection was diagnosed by the enzyme linked immunosorbent assay and confirmed by Western blot. TB diagnosis was based on consistency of the clinical manifestations, chest X-ray, and microscopic examination. Drug susceptibility testing was done by the proportional method on $L{\ddot{o}}wenstein$-Jensen media. Results: Of 824 HIV patients, 59 (7.2%) were identified as TB co-infected and the majority (86.4%) of them were male. Of the overall TB infected patients, 6 cases (10.2%) showed multidrug-resistant with the mean CD4+ lymphocyte count of $163{\pm}166cells/mm^3$. The main clinical forms of TB were pulmonary (73%). There was a significant (p<0.05) correlation between TB infection and CD4+ lymphocyte counts ${\leq}200cells/mm^3$, gender, prison history, addiction history, and highly active anti-retroviral therapy. Conclusion: We reported novel information on frequency of HIV/TB co-infection and multidrug resistant-TB outcome among co-infected patients that could facilitate better management of such infections on a global scale.
Keywords
Tuberculosis; Human Immunodeficiency Virus; Tuberculosis; Multidrug-Resistant; Iran;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003;16:463-96.   DOI
2 Escombe AR, Moore DA, Gilman RH, Pan W, Navincopa M, Ticona E, et al. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med 2008;5:e188.   DOI
3 Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G. Tuberculosis and HIV co-infection. PLoS Pathog 2012;8:e1002464.   DOI
4 Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One 2013;8:e64915.   DOI
5 Zadeh AO, SeyedAlinaghi S, Hassanzad FF, Hajizadeh M, Mohamadi S, Emamzadeh-Fard S, et al. Prevalence of HIV infection and the correlates among homeless in Tehran, Iran. Asian Pac J Trop Biomed 2014;4:65-8.   DOI
6 Venturini E, Turkova A, Chiappini E, Galli L, de Martino M, Thorne C. Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014;14 Suppl 1:S5.
7 Rafiee S, Besharat S, Jabbari A, Golalipour F, Nasermoaadeli A. Epidemiology of tuberculosis in northeast of Iran: a population-based study. Iran J Med Sci 2009;34:193-7.
8 Masjedi MR, Tabarsi P, Chitsaz E, Baghaei P, Mirsaeidi M, Amiri MV, et al. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006. Int J Tuberc Lung Dis 2008;12:750-5.
9 Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: clinical update. Clin Infect Dis 2010;50:1377-86.   DOI
10 Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011;24:351-76.   DOI
11 Farazi A, Sofian M, Zarrinfar N, Katebi F, Hoseini SD, Keshavarz R. Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran. Caspian J Intern Med 2013;4:785-9.
12 Wondimeneh Y, Muluye D, Belyhun Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes 2012;5:331.   DOI
13 Rabirad N, Mohammad Nejad E, Hadizadeh MR, Begjan J, Ehsani SR. The Prevalence of Tb in HIV Patients and Risk Factor With Frequent Referral (Iran, 2009-10). Iran Red Crescent Med J 2013;15:58-61.   DOI
14 Tabarsi P, Mirsaeidi SM, Amiri M, Mansouri SD, Masjedi MR, Velayati AA. Clinical and laboratory profile of patients with tuberculosis/HIV coinfection at a national referral centre: a case series. East Mediterr Health J 2008;14:283-91.
15 Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis-HIV coinfection: policy and epidemiology in 25 countries in the WHO European region. HIV Med 2008;9:406-14.   DOI
16 Khue PM, Phuc TQ, Hung NV, Jarlier V, Robert J. Drug resistance and HIV co-infection among pulmonary tuberculosis patients in Haiphong City, Vietnam. Int J Tuberc Lung Dis 2008;12:763-8.
17 Olaniran O, Hassan-Olajokun RE, Oyovwevotu MA, Agunlejika RA. Prevalence of tuberculosis among HIV/AIDS patients in Obafemi Awolowo University Teaching Hospital Complex Oauthc, ILE-IFE. Int J Biol Med Res 2011;2:874-7.
18 Santos Mde L, Ponce MA, Vendramini SH, Villa TC, Santos NS, Wysocki AD, et al. The epidemiological dimension of TB/HIV co-infection. Rev Lat Am Enfermagem 2009;17:683-8.   DOI
19 Carvalho BM, Monteiro AJ, Pires Neto Rda J, Grangeiro TB, Frota CC. Factors related to HIV/tuberculosis coinfection in a Brazilian reference hospital. Braz J Infect Dis 2008;12:281-6.   DOI
20 Young BN, Rendon A, Rosas-Taraco A, Baker J, Healy M, Gross JM, et al. The effects of socioeconomic status, clinical factors, and genetic ancestry on pulmonary tuberculosis disease in northeastern Mexico. PLoS One 2014;9:e94303.   DOI
21 Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011;101:654-62.   DOI
22 Deribew A, Tesfaye M, Hailmichael Y, Negussu N, Daba S, Wogi A, et al. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes 2009;7:105.   DOI
23 Akinbami AA, Adegboyega AO, Oshinaike OO, Adebola PA, Enabulele C, Dosunmu OA, et al. Chest X- ray findings in HIV patients in relation to the CD4 count. Nig Q J Hosp Med 2011;21:306-11.
24 Kantipong P, Murakami K, Moolphate S, Aung MN, Yamada N. Causes of mortality among tuberculosis and HIV co-infected patients in Chiang Rai, Northern Thailand. HIV AIDS (Auckl) 2012;4:159-68.
25 Lee CH, Hwang JY, Oh DK, Kee MK, Oh E, An JW, et al. The burden and characteristics of tuberculosis/human immunodeficiency virus (TB/HIV) in South Korea: a study from a population database and a survey. BMC Infect Dis 2010;10:66.   DOI
26 Swaminathan S, Nagendran G. HIV and tuberculosis in India. J Biosci 2008;33:527-37.   DOI
27 Masjedi MR, Farnia P, Sorooch S, Pooramiri MV, Mansoori SD, Zarifi AZ, et al. Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran. Clin Infect Dis 2006;43:841-7.   DOI
28 Varahram M, Nasiri MJ, Farnia P, Mozafari M, Velayati AA. A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients. Open Microbiol J 2013;8:1-5.
29 Chaychuk TA, Gankina NU, Nikonova OG. Epidemiology of HIV-associated tuberculosis (TB) co-infection in Krasnoyarsk region, Russian Federation. J Int AIDS Soc 2010;13(Suppl 4):P193.   DOI